Safety and Biomarker Analysis of NRG-LU004: Phase I Trial of Accelerated or Conventionally Fractionated Radiotherapy Combined With Durvalumab in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer.

Lin SH, Pugh SL, Valle DMD, Roudko V, Edelman MJ, Doemer AJ, Simone CB 2nd, Nie K, Rizakos T, Mugunthan A, Zhang R, Kelly G, Beckmann N, Thompson RC, Schulze SK, Gonzalez-Kozlova E, Gandhi S, Bikkina S, Karim N, Shen X, Badiyan SN, Higgins KA, Chakravarti A, Werner-Wasik M, Schallenkamp JM, Suarez-Farinas M, Gnjatic S, Tsao AS, Bradley JD

Open source

DOI: 10.1016/j.ijrobp.2026.08.075
Published: 2026 Sep 12
Container: International journal of radiation oncology, biology, physics
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijrobp.2026.08.075,
  title = {Safety and Biomarker Analysis of NRG-LU004: Phase I Trial of Accelerated or Conventionally Fractionated Radiotherapy Combined With Durvalumab in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer.},
  author = {Lin SH and Pugh SL and Valle DMD and Roudko V and Edelman MJ and Doemer AJ and Simone CB 2nd and Nie K and Rizakos T and Mugunthan A and Zhang R and Kelly G and Beckmann N and Thompson RC and Schulze SK and Gonzalez-Kozlova E and Gandhi S and Bikkina S and Karim N and Shen X and Badiyan SN and Higgins KA and Chakravarti A and Werner-Wasik M and Schallenkamp JM and Suarez-Farinas M and Gnjatic S and Tsao AS and Bradley JD},
  year = {2026},
  journal = {International journal of radiation oncology, biology, physics},
  doi = {10.1016/j.ijrobp.2026.08.075},
  url = {https://doi.org/10.1016/j.ijrobp.2026.08.075}
}

RIS

TY  - JOUR
TI  - Safety and Biomarker Analysis of NRG-LU004: Phase I Trial of Accelerated or Conventionally Fractionated Radiotherapy Combined With Durvalumab in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer.
AU  - Lin SH
AU  - Pugh SL
AU  - Valle DMD
AU  - Roudko V
AU  - Edelman MJ
AU  - Doemer AJ
AU  - Simone CB 2nd
AU  - Nie K
AU  - Rizakos T
AU  - Mugunthan A
AU  - Zhang R
AU  - Kelly G
AU  - Beckmann N
AU  - Thompson RC
AU  - Schulze SK
AU  - Gonzalez-Kozlova E
AU  - Gandhi S
AU  - Bikkina S
AU  - Karim N
AU  - Shen X
AU  - Badiyan SN
AU  - Higgins KA
AU  - Chakravarti A
AU  - Werner-Wasik M
AU  - Schallenkamp JM
AU  - Suarez-Farinas M
AU  - Gnjatic S
AU  - Tsao AS
AU  - Bradley JD
PY  - 2026
JO  - International journal of radiation oncology, biology, physics
DO  - 10.1016/j.ijrobp.2026.08.075
UR  - https://doi.org/10.1016/j.ijrobp.2026.08.075
ER  -

APA

SH, L., SL, P., DMD, V., V, R., MJ, E., AJ, D., 2nd, S. C., K, N., T, R., A, M., R, Z., G, K., N, B., RC, T., SK, S., E, G., S, G., S, B., N, K., X, S., SN, B., KA, H., A, C., M, W., JM, S., M, S., S, G., AS, T., & JD, B. (2026). Safety and Biomarker Analysis of NRG-LU004: Phase I Trial of Accelerated or Conventionally Fractionated Radiotherapy Combined With Durvalumab in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer.. International journal of radiation oncology, biology, physics. https://doi.org/10.1016/j.ijrobp.2026.08.075

Source records

pubmed · retrieved 2026-09-25T08:09:28.049Z